THEY TRUST US

OUR CLIENTS

We started operations in 2019. Despite the few months we have been in business and the particular environment we all are in, leading pharma corporations have already experienced the value of our insights.  
pfizer.png
greenstone.png
regeneron.jpeg
boehringer ingelheim.png
mylan.jpg
sunonvon.png
Acadia.jpg
Gelesis.jpg
Pre-launch Study Evaluations gave us the insights that informed Phase 3 study design in time for us to include critical payer endpoints.
Formulary Insights guarantees the most authentic and reliable payer insights available.

Are you ready to ask all your questions to current P&T members?